Answers are grounded in this paper and cite their sources.
Analysis shows anthracycline response relates to markers in young breast cancer patients, suggesting age-specific treatment insights.
In BC, hsa-miR-26b-5p and hsa-miR-186-5p exhibited pronounced age-specific regulatory patterns and could be considered potential markers of BC course and efficacy of anthracycline-based therapy.
No takes yet. Share an insight, caveat, or question.
Martyniuk et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: